Bio-Labs Launched Omezka (Omeprazole B.P) To Its Extensive Portfolio

Bio-Labs is thrilled to announce the launch of Omezka (Omeprazole B.P.) in our Pain and Gut Care Division. Omezka (Omeprazole B.P) is used to treat excess stomach acid in conditions such as non-cancerous stomach ulcers, gastroesophageal reflux disease (GERD), active duodenal ulcer, Zollinger-Ellison syndrome, and erosive esophagitis. Omeprazole works by blocking gastric acid production and is from a group of medicines called Proton Pump Inhibitors.

At Bio-Labs, we are dedicated to advancing healthcare through innovation. Omezka stands as a testament to our commitment to well-being!

Bio-Labs Launched Lactenem (Meropenem USP) in Anti-infective Division

We at Bio-Labs are thrilled to unveil Lactenem (Meropenem USP) 500mg and 1gm IV Injection, a sterile and pyrogen-free synthetic carbapenem antibiotic designed for intravenous administration. Lactenem (Meropenem USP), offers a broad-spectrum solution for a range of infections in both adults and children. It is used to treat severe pneumonia, broncho-pulmonary infections in cystic fibrosis, complicated urinary tract infections, complicated intra-abdominal infections, intra and post-partum infections, and acute bacterial meningitis.

At Bio-Labs, we believe in the power of precise healthcare, and Lactenem (Meropenem USP) is proof of our dedication to advance and effective antibiotic therapy.

Launching of Nextone (Ceftriaxone Sodium USP) I.V and I.M Injection

Bio-Labs is proud to announce the launch of Nextone (Ceftriaxone Sodium USP) I.V and I.M injection. Ceftriaxone is a third-generation cephalosporin antibiotic and has broad-spectrum activity. Nextone (Ceftriaxone Sodium USP) is used for the treatment of susceptible infections which include abdominal infections including Gastroenteritis (invasive salmonellosis; shigellosis), peritonitis, and biliary tract infections. Genital infections include gonorrhea, chancroid, Meningitis, septicemia, surgical infection (prophylaxis), Whipple’s disease, Lyme disease, Renal urinary, and respiratory tract infections.

Bio-Labs Launched Cetozek (Paracetamol) Infusion

Bio-Labs is pleased to announce Cetozek (Paracetamol) Infusion to Analgesic Division.

Paracetamol IV Infusion is an antipyretic medicine that contains paracetamol as an active ingredient. It is used as first-line therapy for the treatment of fever and pain. It provides fast and effective relief from moderate to severe pain associated with/without fever. It decreases the intensity of pain signals to the brain and also prevents the release of certain chemical messengers (prostaglandins) in the brain that causes pain and fever.